IL130876A0 - Eukaryotic gene expression cassette and uses thereof - Google Patents
Eukaryotic gene expression cassette and uses thereofInfo
- Publication number
- IL130876A0 IL130876A0 IL13087698A IL13087698A IL130876A0 IL 130876 A0 IL130876 A0 IL 130876A0 IL 13087698 A IL13087698 A IL 13087698A IL 13087698 A IL13087698 A IL 13087698A IL 130876 A0 IL130876 A0 IL 130876A0
- Authority
- IL
- Israel
- Prior art keywords
- expression cassette
- gene expression
- eukaryotic gene
- herpes simplex
- simplex virus
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 title abstract 4
- 241000700584 Simplexvirus Species 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000007774 longterm Effects 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
- 230000007733 viral latency Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
- C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9700411.3A GB9700411D0 (en) | 1997-01-10 | 1997-01-10 | Eukaryotic gene expression cassette and uses thereof |
| PCT/GB1998/000074 WO1998030707A2 (en) | 1997-01-10 | 1998-01-12 | Eukaryotic gene expression cassette and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL130876A0 true IL130876A0 (en) | 2001-01-28 |
Family
ID=10805768
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13087698A IL130876A0 (en) | 1997-01-10 | 1998-01-12 | Eukaryotic gene expression cassette and uses thereof |
| IL130876A IL130876A (en) | 1997-01-10 | 1999-07-09 | A cassette for expressing genes in eukaryotes and its use |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL130876A IL130876A (en) | 1997-01-10 | 1999-07-09 | A cassette for expressing genes in eukaryotes and its use |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP1021553B1 (ko) |
| JP (1) | JP2001508294A (ko) |
| KR (1) | KR100507399B1 (ko) |
| CN (1) | CN1231589C (ko) |
| AT (1) | ATE267263T1 (ko) |
| AU (1) | AU749064B2 (ko) |
| BR (1) | BR9806866A (ko) |
| CA (1) | CA2278326A1 (ko) |
| DE (1) | DE69824027T2 (ko) |
| DK (1) | DK1021553T3 (ko) |
| ES (1) | ES2221980T3 (ko) |
| GB (1) | GB9700411D0 (ko) |
| IL (2) | IL130876A0 (ko) |
| PT (1) | PT1021553E (ko) |
| WO (1) | WO1998030707A2 (ko) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9801930D0 (en) | 1998-01-29 | 1998-03-25 | Univ London | Mutant herpes simplex viruses and uses thereof |
| GB9807865D0 (en) * | 1998-04-09 | 1998-06-10 | Univ London | Herpes simplex virus latency associated transcript polypeptides |
| JP2002523024A (ja) * | 1998-07-31 | 2002-07-30 | ケンブリッジ ユニバーシティ テクニカル サービシズ リミティド | ヘルペスウイルスの潜伏活性調節配列及び遺伝子運搬のための潜伏不活性ヘルペスウイルス |
| US6713067B2 (en) | 1998-07-31 | 2004-03-30 | Biovex Limited | Herpes viruses for immune modulation |
| GB9930418D0 (en) * | 1999-12-22 | 2000-02-16 | Neurovex Ltd | Replication incompetent herpes virus vectors |
| US7063851B2 (en) | 2000-04-12 | 2006-06-20 | Biovex Limited | Herpes viruses for immune modulation |
| US7514110B1 (en) | 2000-09-21 | 2009-04-07 | Basf Aktiengesellschaft | Talaromyces xylanases |
| AUPR518501A0 (en) | 2001-05-22 | 2001-06-14 | Unisearch Limited | Yin yang-1 |
| TWI328612B (en) | 2002-07-25 | 2010-08-11 | Dsm Ip Assets Bv | Genes and their encoded polypeptides involved in the biosynthetic pathway of vitamin b12, vectors and host cells comprising the genes, and process for producing vitamin b12 |
| JP2006500062A (ja) * | 2002-09-27 | 2006-01-05 | パウダージェクト リサーチ リミテッド | 遺伝子発現のための核酸構築物 |
| GB0317511D0 (en) | 2003-07-25 | 2003-08-27 | Biovex Ltd | Viral vectors |
| WO2005080581A2 (en) * | 2004-02-17 | 2005-09-01 | University Of Florida Research Foundation, Inc. | Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression |
| US9593347B2 (en) | 2010-04-16 | 2017-03-14 | University of Pittsburgh—of the Commonwealth System of Higher Education | Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors |
| EP3022307A4 (en) * | 2013-07-17 | 2017-04-19 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Non-toxic hsv vectors for efficient gene delivery applications and complementing cells for their production |
| RU2719190C2 (ru) | 2013-10-28 | 2020-04-17 | Юниверсити Оф Питтсбург- Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн | Онколитический hsv-вектор |
| CN109153977B (zh) | 2016-01-08 | 2022-11-01 | 雷普利穆内有限公司 | 溶瘤病毒株 |
| DK3408382T3 (da) | 2016-01-27 | 2022-06-20 | Oncorus Inc | Onkolytiske virale vektorer og anvendelser deraf |
| GB201700350D0 (en) * | 2017-01-09 | 2017-02-22 | Replimune Ltd | Altered virus |
| RU2771110C2 (ru) | 2017-07-26 | 2022-04-26 | Онкорус, Инк. | Онколитические вирусные векторы и их применение |
| WO2020243706A1 (en) * | 2019-05-30 | 2020-12-03 | Solid Biosciences Inc. | Recombinant herpesvirales vector |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849571A (en) * | 1990-10-10 | 1998-12-15 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Latency active herpes virus promoters and their use |
| PT566554E (pt) * | 1992-03-13 | 2000-09-29 | Monsanto Co | Producao de proteinas recombinantes usando promotores do virus de herpes e transactivadores vp16 |
-
1997
- 1997-01-10 GB GBGB9700411.3A patent/GB9700411D0/en active Pending
-
1998
- 1998-01-12 DK DK98900570T patent/DK1021553T3/da active
- 1998-01-12 EP EP98900570A patent/EP1021553B1/en not_active Expired - Lifetime
- 1998-01-12 AU AU55669/98A patent/AU749064B2/en not_active Ceased
- 1998-01-12 IL IL13087698A patent/IL130876A0/xx not_active IP Right Cessation
- 1998-01-12 ES ES98900570T patent/ES2221980T3/es not_active Expired - Lifetime
- 1998-01-12 PT PT98900570T patent/PT1021553E/pt unknown
- 1998-01-12 WO PCT/GB1998/000074 patent/WO1998030707A2/en active IP Right Grant
- 1998-01-12 DE DE69824027T patent/DE69824027T2/de not_active Expired - Lifetime
- 1998-01-12 EP EP04008341A patent/EP1441033A3/en not_active Withdrawn
- 1998-01-12 CA CA002278326A patent/CA2278326A1/en not_active Abandoned
- 1998-01-12 CN CNB988032147A patent/CN1231589C/zh not_active Expired - Fee Related
- 1998-01-12 JP JP53066398A patent/JP2001508294A/ja not_active Ceased
- 1998-01-12 AT AT98900570T patent/ATE267263T1/de not_active IP Right Cessation
- 1998-01-12 KR KR10-1999-7006256A patent/KR100507399B1/ko not_active IP Right Cessation
- 1998-01-12 BR BR9806866-0A patent/BR9806866A/pt not_active Application Discontinuation
-
1999
- 1999-07-09 IL IL130876A patent/IL130876A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998030707A3 (en) | 1998-09-11 |
| KR100507399B1 (ko) | 2005-08-10 |
| DK1021553T3 (da) | 2004-09-27 |
| CN1250480A (zh) | 2000-04-12 |
| BR9806866A (pt) | 2000-04-18 |
| AU5566998A (en) | 1998-08-03 |
| ES2221980T3 (es) | 2005-01-16 |
| DE69824027T2 (de) | 2004-10-28 |
| ATE267263T1 (de) | 2004-06-15 |
| CA2278326A1 (en) | 1998-07-16 |
| GB9700411D0 (en) | 1997-02-26 |
| IL130876A (en) | 2006-08-20 |
| DE69824027D1 (de) | 2004-06-24 |
| EP1441033A2 (en) | 2004-07-28 |
| EP1021553B1 (en) | 2004-05-19 |
| PT1021553E (pt) | 2004-09-30 |
| AU749064B2 (en) | 2002-06-20 |
| EP1441033A3 (en) | 2004-12-01 |
| CN1231589C (zh) | 2005-12-14 |
| JP2001508294A (ja) | 2001-06-26 |
| EP1021553A2 (en) | 2000-07-26 |
| WO1998030707A2 (en) | 1998-07-16 |
| KR20000070037A (ko) | 2000-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9700411D0 (en) | Eukaryotic gene expression cassette and uses thereof | |
| AU6663096A (en) | Viral vectors and line for gene therapy | |
| AU6149596A (en) | Tumor- or cell-specific herpes simplex virus replication | |
| DE3586520D1 (de) | Herpes simplex-virus als vektor. | |
| WO1998027204A3 (en) | AAV split-packaging genes and cell lines comprising such genes for use in the production of recombinant AAV vectors | |
| NO303831B1 (no) | Isolert DNA-sekvens, vektor, vertscelle, polypeptid og anvendelse in vitro av polypeptidet ved en fremgangsmÕte for transfeksjon av hematopoeseceller med eksogen DNA | |
| IE842210L (en) | Vaccine | |
| MX9603002A (es) | Procedimiento para la preparacion de virus asociados a los adenovirus (aav), recombinantes, y usos de los mismos. | |
| AU3675095A (en) | Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell | |
| GR3021426T3 (en) | Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication | |
| AU7097494A (en) | Envelope fusion vectors for use in gene delivery | |
| AU2853395A (en) | Recombinant vectors derived from adenovirus for use in gene therapy | |
| EP0663921A4 (en) | METHOD FOR INCREASING DEGREES OF EXPRESSION AND REDUCING THE VARIABILITY OF EXPRESSION OF FOREIGN GENES IN PLANT CELLS. | |
| HK161295A (en) | Vector for integration site independent gene expression in mammalian host cells | |
| AU1278695A (en) | Homologous recombination antibody expression system for murine cells | |
| WO1998055639A3 (fr) | Vecteurs adenoviraux recombinants comprenant une sequence d'epissage | |
| AU3868197A (en) | Yeast vectors and process for producing proteins with the use of the same | |
| AU5318496A (en) | Adenovirus vectors for gene therapy | |
| SI1212428T1 (en) | Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression | |
| AU582288B2 (en) | Vector and method for achieving high level expression in eukaryotic cells | |
| AU692395B2 (en) | Recombinant herpesvirus with the use of gB gene promoter | |
| WO1997014808A3 (en) | Herpesvirus vectors and their uses | |
| AU2233297A (en) | Promoter | |
| IE862793L (en) | Plasmid expression in yeast | |
| EP0165614A3 (en) | Hybrid plasmid and microorganism containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| MM9K | Patent not in force due to non-payment of renewal fees |